Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 06/23/2025 3:20:56 PM
Board Marks: 278
Posts Today: 0
Board Views Today: 1015
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
49157
If both Galera's GC4419 and Brilacidin get
(1)
RusticBum
09/23/2018 11:57:00 AM
49156
Accusing long term investors of being short multi
(2)
bejamin
09/23/2018 11:42:25 AM
49155
It's always good to have more than one treatment
(3)
Drano
09/22/2018 3:41:30 PM
49154
Could be a second line treatment after B-OM was
Trading Pro Broker
09/22/2018 3:36:35 PM
49153
NO way will an insurance company pay for that
(2)
smokenhot
09/22/2018 3:24:06 PM
49152
He's accusing long-time posters of being
(5)
Drano
09/22/2018 2:27:16 PM
49150
Take a look at Galas OM drug. Its
(1)
Trading Pro Broker
09/22/2018 1:38:41 PM
49149
Id like to see Leo take half his compensation
(2)
Commando911
09/22/2018 1:19:15 PM
49148
I have never heard of a long multi-identity in
(2)
petemantx
09/22/2018 1:10:28 PM
49147
Your right. That would be
Trading Pro Broker
09/22/2018 11:11:42 AM
49146
A reminder on how to use the Ignore feature:
Drano
09/22/2018 11:02:08 AM
49145
It's typical of many companies to have a large
(4)
Drano
09/22/2018 11:00:23 AM
49144
Multi identities on both sides create so much
(2)
bejamin
09/22/2018 10:59:06 AM
49143
I dont think it is a surprise. If it surprises
Trading Pro Broker
09/22/2018 10:48:51 AM
49142
Glad you're not running the company!
(1)
bejamin
09/22/2018 10:43:09 AM
49141
really, it is better not to respond to trolling
(1)
Drano
09/22/2018 10:00:01 AM
49140
So you think IPIX will begin testing on autism,
(1)
smokenhot
09/22/2018 9:01:20 AM
49139
Well seeing as you came from Yahoo I can
bejamin
09/22/2018 5:10:05 AM
49138
I don't know why this comes as any surprise. Dr.
(12)
Drano
09/21/2018 9:59:42 PM
49137
Yup 1 month here and 5 years on Yahoo. Maybe you
(4)
smokenhot
09/21/2018 9:19:33 PM
49136
No they have not. IPIX has other pre clinical
bejamin
09/21/2018 8:48:07 PM
49135
They have ALL gone thru Pre Clinical. What don't
smokenhot
09/21/2018 8:25:49 PM
49134
To bring new drugs online. IPIX has other drugs
bejamin
09/21/2018 7:37:42 PM
49133
Why would they restart R&D? They are a clinical
(2)
smokenhot
09/21/2018 6:31:27 PM
49132
Arent 18M of those options? Cant exercise
Trading Pro Broker
09/21/2018 6:25:43 PM
49131
As of 6/19/18 Menon has over 33M reasons to see
(1)
Mo
09/21/2018 6:06:58 PM
49130
Totally agree. He'll probably get board payments
incubus
09/21/2018 6:04:21 PM
49129
14% marked today! Go IPIX!!!
(1)
AlanC
09/21/2018 5:53:25 PM
49128
I wondered why he needed to hang around. His work
Trading Pro Broker
09/21/2018 5:52:29 PM
49127
I think scgmck1's post got spell checked from
(2)
Mo
09/21/2018 5:39:37 PM
49126
Who's employment?
Loose Lips
09/21/2018 5:29:36 PM
49125
8K out on the company website. Says mean on his
scgmck1
09/21/2018 5:04:11 PM
49124
They are running out of time. Cover those shorts
incubus
09/21/2018 4:08:53 PM
49123
Close at .299 again? hahaha they just can't allow
Drano
09/21/2018 4:03:10 PM
49122
I agree but I am not expecting news until 9/30
(3)
AlanC
09/21/2018 3:54:18 PM
49121
No prisoners!
(1)
incubus
09/21/2018 3:42:55 PM
49120
Now that most have seen the bad-faith postings of
(6)
Drano
09/21/2018 2:05:07 PM
49118
It was well written. And seeing both Leo and Dr.
(2)
BooDog
09/21/2018 1:39:00 PM
49116
Emailed yesterday's PR to a couple of friends
(3)
AlanC
09/21/2018 1:00:39 PM
49115
Yeah, that crap gives me a headache. Maybe they
(5)
BooDog
09/21/2018 12:25:50 PM
49114
Any more ludicrous taunting of genuine investors
(2)
Drano
09/21/2018 12:21:48 PM
49112
Its a weekend. Deals can get done. Would be
(2)
Trading Pro Broker
09/21/2018 11:29:46 AM
49111
Anybody notice that Dr. B left off Hidradenitis
(1)
smokenhot
09/21/2018 11:03:08 AM
49110
Quite a volume difference, only 63,655 as opposed
(1)
Drano
09/21/2018 10:57:21 AM
49108
Mid .30's potential imo. Anticipation. Bring on
BooDog
09/21/2018 10:40:22 AM
49107
FDA says: well, they're gonna die anyway, we'll
Drano
09/21/2018 9:58:20 AM
49106
That makes sense to me. Thanks.
Loose Lips
09/21/2018 9:47:00 AM
49105
The upfronts will get smaller relative to the
(4)
Squar
09/21/2018 8:41:57 AM
49104
$50M per IND upfront would be good. We have a lot
(2)
Trading Pro Broker
09/21/2018 7:39:40 AM
49103
Getting the oral formulations completed. That's
BooDog
09/21/2018 7:30:06 AM
Newer
Older
Recent Articles
Tarkett Celebrates EcoVadis Platinum Medal Achievement
Huhtamaki Introduces Eco-Friendly Compostable Ice Cream Cups
FLSmidth's Strategic Share Buy-back Program Performance Review
Serstech Experiences Challenges in Q2 2025 Performance
Quadient Strengthens Presence with Vizient Supplier Agreement
Tarkett Achieves EcoVadis Platinum Medal for Sustainability Success
Larry Ellison's Rise: How Oracle's AI Strategies Boosted His Wealth
Sobi Reports Q2 2025: Strong Financial Growth and Outlook
Insights from Serstech Group's Second Quarter Report
Unlocking Bitcoin's Potential: Galaxy Digital's Investment in Function
Trianz Unveils Groundbreaking Solutions at AWS Summit NYC 2025
Unlocking the Future: The Role of Trust in AI Advancement
Sobi Reports Q2 2025: Impressive Growth and Future Outlook
Sobi Reports Robust Performance in Q2 2025 Financials
Explore CJB Crypto's Innovative Green Mining Solutions
Join Tetragon Financial Group Limited for Upcoming Investor Call
Synovus Financial Earnings Expectations and Analyst Insights
Exploring Growth in the Projection Mapping Industry Through 2032
ICG Achieves Strong Growth with $123bn in Q1 Trading
Hofseth BioCare's ProGo® Triumphs at NutraIngredients Awards
IMCD Strengthens Leadership with New Executive Appointments
Nilörn Group Sees Mixed Financial Results for Q2 2025
Kenmare Resources Q2 2025 Production Update Highlights
Foresight Group's Strategic Share Buyback Initiative Explained
Caledonia Mining Reports Record Gold Production in Q2 2025
Stellantis Shifts Focus Away from Hydrogen Fuel Cell Development
Bitget Expands Token Offerings with Eclipse Listing and Rewards
Hofseth BioCare's ProGo® Earns Top Honors for Healthy Aging
Leadership Changes at IMCD to Enhance Global Operations
Kenmare Resources Reports Solid Production Results for 2025
ICG's Q1 Performance Review: Insights on Fundraising Growth
Nilörn Reports Insights from Q2 2025 Business Performance
Tetragon Financial Group: Upcoming Investor Call Insights
Xlence Unveils Trading Central Suite for Enhanced Trading Success
Innovative Global Healthcare Challenge Spotlights Emerging Startups
Elevating In-Car Entertainment: LG's webOS in New Kia Models
Experience Premium In-Car Entertainment with LG and Kia
ESET PROTECT Complete: Leaders in Cybersecurity Solutions 2025
Richemont Achieves Strong Growth in Q1 Sales Performance
Economist Peter Schiff Forecasts Market Reaction to Trump’s Tariffs
Nuwellis Achieves Significant Growth with New Patent Approval
Alm. Brand Group Reports Impressive Q2 Financial Results
Ocuco Faces Scrutiny After Massive Data Breach Affecting Patients
London Properties, Inc. Faces Scrutiny Over Data Breach
Investigation into ACCU Reference Medical Lab for Data Breach
Innovative Cybersecurity Solutions Earn Penta Recognition
ESET PROTECT Complete: The Future of Malware Protection
Promising Q2 Results: Alm. Brand Group's Solid Performance Overview
DNO ASA Temporarily Halts Operations Amidst Unexpected Incidents
Bitget Wallet Launches Weekly Staking Event with PUMP Tokens